Validation of the <scp>VE1</scp> immunostain for the <i><scp>BRAF</scp></i><scp>V600E</scp> mutation in melanoma

Abstract

This hospital-based study finds high sensitivity and specificity for the BRAF VE1 immunostain in comparison to pyrosequencing in detection of BRAF V600E in melanomas.